Eloxx Pharmaceuticals Announces Participation in the HIT-CF Project on Cystic Fibrosis
WALTHAM, Mass., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc., (NASDAQ: ELOX) a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat cystic fibrosis, inherited retinal diseases …